Delivery Order SPE2DB20D2104-SPE2DB22FS89B

Award Date 6/1/22
Potential Completion Date 6/2/22
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,739.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $4,511.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, which serves as...
This federal contract award is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,616.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $14,068.58 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support military healthcare programs. The award is under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,138.64 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $2,128.13 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,570.32 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order valued at $10,664.36 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through December 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,372.08, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves...
This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,176.39 firm fixed-price delivery order contract has a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS89B
    Delivery Order

This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $13,908.63 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen leverages its extensive supply chain and distribution capabilities to fulfill essential pharmaceutical and medical commodity requirements across multiple government agencies.

Generated 2/27/25, 11:57 AM